PLx Pharma Winddown Corp.
PLXPQ
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -27.58M | -40.72M | -45.37M | -46.12M | -57.67M |
| Total Depreciation and Amortization | 218.20K | 233.20K | 165.20K | 213.20K | 260.40K |
| Total Amortization of Deferred Charges | 300.00 | 300.00 | 300.00 | 3.30K | 14.00K |
| Total Other Non-Cash Items | -32.44M | -18.80M | -6.48M | 8.38M | 36.49M |
| Change in Net Operating Assets | 460.40K | 1.93M | 6.95M | 5.41M | -367.70K |
| Cash from Operations | -59.34M | -57.35M | -44.73M | -32.12M | -21.28M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 500.00 | 49.50K | 94.50K | 94.50K | 94.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 500.00 | 49.50K | 94.50K | 94.50K | 94.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -625.00K | -1.56M |
| Issuance of Common Stock | 2.61M | 12.86M | 12.71M | 79.59M | 96.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -300.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.61M | 12.86M | 12.71M | 78.97M | 94.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.72M | -44.44M | -31.93M | 46.94M | 73.47M |